FOLLICULAR LYMPHOMA ( FL)
Clinical trials for FOLLICULAR LYMPHOMA ( FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA ( FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA ( FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot immune cell therapy battles standard care for stubborn blood cancer
Disease control OngoingThis study is testing whether a single infusion of a personalized immune cell therapy (tisagenlecleucel) works better than current standard drug treatments for adults with follicular lymphoma that has come back or stopped responding to prior therapies. It involves about 109 parti…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Major cancer trial pits new drug against standard treatment in race to control lymphoma
Disease control OngoingThis large Phase 3 trial is comparing a new drug combination against the current standard treatment for people newly diagnosed with follicular lymphoma, a type of blood cancer. About 733 participants will receive either the experimental drug odronextamab plus chemotherapy or the …
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC